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Abstract
Background and Objective: Treacher Collins syndrome, also called mandibula-facial dysostosis, is a congenital disorder. It is the aim of this work to clarify the 
etiology, diagnosis, phenotypic craniofacial and oral characteristics of the syndrome, as well as to discuss the treatments to be applied.
Methods: A bibliographic search was performed using the keywords: "Treacher Collins Syndrome", "treatment", "dental", "oral cavity", "TCOF1 gene".
Results: Most cases have an autosomal dominant transmission and variable expressivity. Mutations in the TCOF1 gene on chromosome 5 are usually known to cause 
Treacher Collins syndrome. The phenotypic craniofacial features are: micrognathia, maxillary hypoplasia with palate cleft, malar hypoplasia, antimongoloid inclination 
of palpebral fissures, coloboma of lower eyelid and microtia. Problems in the oral cavity are frequent in these patients because the deficiencies of the bone bases provoke 
crowding and can lead to incorrect bite. Other oral manifestations include reduced salivary flow, high levels of caries and plaque. 
Conclusions: Diagnosis and treatment should be performed in an early stage and are important for the reestablishment of masticatory, respiratory and auditory 
functions.
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Introduction
The Treacher Collins syndrome (TCS), also known as mandibula-
facial dysostosis or Franceschetti-Zwahlen-Klein syndrome, is 
a congenital pathology characterised by abnormal craniofacial 
development resulting from changes in embryo development of the 
first and second gill arches between the fifth and eight weeks of foetal 
development [1]. It is a rare condition with an incidence of 1:50.000 live 
births [2], without predisposition for sex or race [3].
It is caused by mutations on the TCOF1 gene, but other two genes 
have also been identified. 
Around 40% of all cases of this syndrome have a hereditary origin, 
while the remaining 60% result from de novo mutations [4].
Clinical characteristics of this syndrome are usually bilateral and 
relatively symmetrical [5] and patients also show multiple oral changes 
[6,7]. The craniofacial anomalies present in these patients may lead to 
chewing, breathing and speech problems that should be evaluated as a 
priority [8].
The treatment of this condition requires a multidisciplinary 
approach based on the degree of dysmorphology and growth of each 
anatomical region in order to optimize both functional and aesthetic 
rehabilitation [9].
Differential diagnosis should be made with other clinical entities 
that have features common to this disease, such as Nager, Miller, 
Goldenhar and Pierre Robin syndromes [10].
The main objective of this work is to obtain a deeper knowledge of 
the most frequent genetic factors, craniofacial characteristics and oral 
manifestations, in order to offer them a valid dental treatment adapted 
to their needs.
For this work, a bibliographic search was performed using the 
websites PubMed, SciELO and ScienceDirect.
The keywords used were: "Treacher Collins Syndrome", "treatment", 
"dental", "oral cavity", "TCOF1 gene". The selection criteria of the 
articles were: date of publication between 2012 and 2019 and written in 
Portuguese, English, Spanish or French. Papers prior to 2012 were also 
selected according with the relevance of the theme. 
Treacher Collins Syndrome
Historical Considerations
This syndrome was first described by Thompson in 1846. Later, in 
1889, George Andreas Berry described the syndrome as a congenital 
disease with coloboma of the lower parates. The name of this syndrome 
comes from the English ophthalmologist Edward Treacher Collins, 
who, in 1900 diagnosed the condition in 2 patients with these eye 
sequelae and thus determined the essential features of this condition 
[11].
In 1940, Adolphe Franceschetti together with David Klein 
published numerous review papers where they characterized facial 
features and adopted for this condition the name mandibulofacial 
dysostosis [12].
Duque C (2019) Treacher Collins syndrome and implications in the oral cavity
 Volume 5: 2-5Clin Res Trials, 2019        doi: 10.15761/CRT.1000278
Clinical features
The symptoms and severity of this syndrome differ from individual 
to individual, even among members of the same family. However, there 
are distinctive and well-described clinical features [20].
The clinical features of Treacher Collins Syndrome reflect the 
abnormal embryonic development of structures derived from the first 
and second pharyngeal arches. Most of the present changes are bilateral 
with relatively symmetrical distribution [21].
Some of the main symptoms of Treacher Collins Syndrome are 
malar hypoplasia, maxillary and mandibular hypoplasia and bilateral 
microtia or annotation [22].
In general, patients present alterations of the external ear or even 
absence of it. This is accompanied by atresia or stenosis of the external 
acoustic meatus, so hearing loss which is usually bilateral is very likely. 
At the middle ear level there is ankylosis of the ossicles or absence of 
them [23]. The facial profile of these patients is dramatically convex due 
to marked micrognathia [24]. Micrognathia along with glosoptosis may 
lead to a greater predisposition to airway obstruction, which may lead 
to feeding and breathing problems [25].
Ocular changes are frequent and include antimongoid tilt of 
the eyelid fissures, lower eyelid coloboma and partial absence of 
eyelashes in the lower eyelid. Occasionally, patients may have vision 
loss, strabismus, congenital cataracts and even microphthalmia or 
anophthalmia. Despite these changes, vision is usually normal because 
the retina does not develop from the affected branchial arches. Thus, 
most patients maintain at least one eye with normal vision [20].
Due to bone malformation, swallowing, chewing, speech and 
breathing are affected. There are also manifestations in other areas 
of the body such as congenital heart disease, cryptorchidism and 
malformation of the cervical spine and extremities [26].
Cognitive development is usually normal but is affected by speech 
development problems resulting from hearing loss or cleft palate [27].
Oral characteristics: Regarding the oral cavity, high levels of plaque 
and low effectiveness of tooth brushing have been described in patients 
with TCS [28]. In addition, these patients experience reduced saliva 
flow as a result of salivary gland pathology. This factor along with others 
like mouth breathing, crowding and soft diet contribute to high levels 
of tooth decay. However, studies in children and adults with regular 
dental follow-up have shown a satisfactory oral health standard without 
high caries levels, reflecting the importance of a prophylactic treatment 
[29]. These authors evaluated the prevalence of dental anomalies in 
15 patients with TCS, observing their presence in 60% of them, with 
higher incidence of dental agenesis (33%), especially of the lower 
second premolars, and enamel opacities (20%) [28].
Other manifestations associated with the oral cavity also occur, such 
as unilateral or bilateral macrostomy, ogival palate and occasionally 
cleft palate [10].
In another study, Østerhus, et al. [30] attempted to relate TCS with 
salivary gland pathology and dysfunction in a sample of 21 patients. 
These researchers observed that half of those patients had major 
salivary gland dysplasia or aplasia. However, no significant correlation 
was found between oral dryness complaints and low salivary secretion 
rates. The results suggested an association between TCS and salivary 
gland pathology [30].
Other designations for this syndrome used today are jaw-facial 
dysostosis or Franceschetti-Zwahlen-Klein syndrome [13]. 
Etiopathogeny
TCS is a rare congenital disorder of craniofacial development 
caused by mutations in the TCOF1 gene, located on the long arm of 
chromosome 5 (5q32-q33), or in the POLR1C and POLR1D genes 
present on chromosomes 6 and 12 respectively (6q21.2 and 13q12.2) 
[14].
The TCOF1 gene encodes Treacle nuclear phosphoprotein, 
involved in bone and other facial tissue development during the 
prenatal stage. So far over 200 mutations have been identified in 
this gene and all of them lead to the appearance of a premature stop 
codon. The TCOF1 gene is responsible for most cases (> 90%) of this 
syndrome, having an autosomal dominant transmission. However, in 
many cases mutations in this gene may arise without the presence of 
family history [11].
On the other hand, the POLR1D and POLR1C genes encode the 
D and C subunits of RNA polymerases I and III, respectively, involved 
in the synthesis of ribosomal pre-RNAs and small RNA molecules 
(siRNAs), which are essential for the normal functioning and survival of 
cells [15]. So far, there is a number of identified pathogenic mutations, 
including insertions, deletions, nonsense mutations, and missense 
mutations in these two genes, however, approximately 60% of TCS 
patients have no family history, resulting the syndrome from de novo 
mutations [16]. 
Mutations in these genes alter the structure and function of the 
encoded protein, reducing the amount of RNA polymerases I and III 
in cells, thereby leading to lower rRNA production. Decreased rRNA 
is thought to trigger the apoptosis process in neural ectodermal cells. 
Since these cells are the precursors of the neural crest, neural crest 
cell formation will also be compromised. These cells contribute to the 
formation of bones, cartilage and connective tissue of the head and face. 
This may explain the cranioskeletal hypoplasia characteristic of TCS 
individuals [17].
Thus, Dixon, et al. [18] suggested that the cranioskeletal hypoplasia 
commonly observed in TCS individuals is caused by a deficiency in 
neural crest cells rather than a migration defect of these cells [11,18].
Recent studies show that deficiencies in neural ectodermal and 
neural crest cells result in the activation of the nucleolar stress of the p53 
protein-dependent apoptotic pathway that promotes neuroepithelial 
cell death. This finding raises the possibility that inhibition of p53 
protein activity could block neuroepithelial apoptosis, restore the 
neural crest cell population, and prevent craniofacial anomalies 
characteristic of TCS [17]. However, p53 carries out several important 
cellular functions, including its role as a tumour suppressor. Often p53 
loss results in tumour formation. Therefore, further study is needed 
for a deeper understanding, specifically of non-cancer-linked genes 
and tumour progression as potential candidates for the therapeutic 
prevention of TCS and other craniofacial syndromes [7].
The reason for the clinical variability observed in TCS patients is 
still unknown. Some authors attribute the wide diversity of symptoms 
to environmental factors, interaction with other genes, and the role of 
normal alleles of the TCOF1 gene. So far, no author has been able to 
find a clear relationship between the severity of the clinical picture and 
the type or location of the pathological mutation [11,19].
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A highlight is the hypoplasia of the facial bones, especially of the 
middle third of the face and jaw. This change gives rise to a bird's face 
with a prominent nose and a narrow face with depressed cheeks [31]. 
Jaw hypoplasia can lead to difficulties in breathing and eating. It also 
has repercussions in the oral cavity and may, in most cases, leads to 
dental malocclusion with anterior open bite [32].
Terner, et al. [21] found that mandibular hypoplasia is more severe 
at the proximal level, thus the condyle is the most hypoplastic structure 
followed by the ramus and then the body. This implies a high incidence 
of TMJ dysfunction in these patients, which may cause mouth opening 
limitation [21].
Patients can also develop several diastemas along the arches, 
badly positioned teeth, enamel hypoplasia, temporomandibular joint 
dysplasia, midline deviation, Class II or III malocclusion, prognathism 
or maxillary retrognathism relative to the skull base [28].
Diagnosis
Treacher Collins syndrome presents a very variable clinical picture, 
even among members of the same family, which associated with the 
high rate of de novo mutations can lead to misdiagnosis.
The diagnosis of these patients is essentially clinical and is usually 
made at birth based on the observed clinical manifestations. This 
diagnosis is confirmed by radiographic findings and molecular studies 
[33].
Diagnosis can also be made in the prenatal period by sampling 
chorionic villi (10-12 weeks gestation) or by amniocentesis (15-18 
weeks gestation) [34]. Although molecular analysis has been shown 
to be extremely valuable in prenatal diagnosis, the degree of fetal 
alteration cannot be predicted. Consequently, ultrasound can provide 
information on the severity of affected pregnancies and can be used to 
assess fetal progression by revealing typical facial dysmorphism with 
bilateral ear anomalies [35].
In cases of suspicion in the family, genetic analysis can determine 
the presence of the mutation causing Treacher Collins syndrome, 
allowing to determine changes in the TCOF1, PORL1C and PORL1D 
genes. This is especially important for genetic counselling in high-risk 
families due to the high penetrance and variable expressiveness of the 
syndrome, as the condition may go unnoticed in some individuals who 
may pass it on to offspring [2].
It is important to make a differential diagnosis with other 
syndromes involving craniofacial malformations, such as: Nager, Miller 
and Goldenhar syndromes [36].
Treatment
There is no cure for this condition. Thus, treatment is directed to 
the specific symptoms of each individual. Treatment of this disease 
requires a multidisciplinary approach involving different health 
professionals such as craniofacial surgeons, orthodontists and dentists, 
physiotherapists, paediatricians, psychologists, otolaryngologists and 
ophthalmologists, among other professionals who may be required 
[36].
Patients with TCS usually require numerous surgical procedures and 
staged treatment can continue throughout childhood until adulthood, 
as some surgeries should be postponed until the end of growth. Early 
intervention during the neonatal period and childhood may be necessary 
to ensure airway integrity, nourishment and speech development [20]. 
Thus, early evaluation of possible airway obstruction, resulting from 
retromicrognathy that contributes to the restriction of nasopharyngeal 
spaces, is necessary. In mild cases conservative treatment and prone 
position may be sufficient. If the respiratory obstruction is more severe, 
lip-tongue adhesion or mandibular advancement may be required. In 
more severe cases, intubation or tracheotomy may be required. In cases 
that do not respond satisfactorily to tracheotomy, osteogenic distraction 
of the mandible is an alternative. However, the latter is usually reserved 
to assist decannulation after tracheotomy [37].
Continuous airway monitoring is necessary during child growth, as 
respiratory complications may develop later [38].
In a second stage, between 3 and 12 years old, orthodontic 
treatment, reconstruction of the palate and zygomatic region should 
be started. In addition, otoplasty and other retouching surgeries should 
also be performed during this period.
Although peri-orbital soft tissue defects are well known, true 
ophthalmologic sequelae are rarely mentioned [39]. However, the eyes 
of these patients are characterized by antimongoloid tilt of the eyelid 
fissures resulting from lower eyelid coloboma. In this context, lower 
eyelid colobomas need special attention from birth because they are a 
potential threat to vision [40]. Although eyelid and orbital deformations 
are hallmarks of this syndrome, its correction is usually delayed, 
excluding neonatal tarsorrhaphy in cases with corneal exposure [20].
The cleft palate is a trait usually found in TCS, with an approximate 
incidence of 23%. Cleft palate repair is often delayed until airway 
function is no longer compromised. In addition, after palate repair, 
a higher risk of palate fistula is often reported, although not much 
evidence is provided [41].
Conductive hearing loss is present in most patients, resulting from 
abnormal internal auditory structure and improper functioning of the 
ossicles. Thus, early identification of the cause of hearing loss and its 
correction before school entry is of special importance. An elastic band 
hearing aid can be used in the first years of life [40]. If patients have 
partial microtia or total annotation, the auricle is reconstructed using 
prosthetic devices or an autologous costal cartilage structure [3,20]. 
Even though the cartilage is strong enough from 6 years of age, it is 
preferable to perform the procedures around 9 years of age [3,42].
Cheek reconstruction is usually directed to the correction of absent 
or hypoplastic zygoma. For the increase of zygomatic prominences and 
orbital border, cranial bone graft is generally used, however it has the 
disadvantage of presenting a higher percentage of bone resorption [43].
In a third phase, from 13 to 18 years old, orthognathic surgery 
is advised. In cephalometric analysis, patients with TCS have a short 
and retrognathic jaw, which may lead to glosoptosis and upper airway 
obstruction. The height of the posterior face is reduced, the angle of the 
mandibular plane is increased, and patients may present anterior open 
bite. Usually, the association of Le Fort I maxillary osteotomy, sagittal 
mandible osteotomy and genioplasty is performed. In situations where 
the mandibular deformation is greater, with reduction of the mandibular 
ramus dimensions, osteogenic distraction of the mandibular ramus is 
previously performed to provide greater bone contact in the sagittal 
osteotomy [24].
Finally, nasal reconstruction is performed after orthognathic 
surgery, and according to individual needs [8].
Dental treatment of patients with Treacher Collins syndrome: 
Dental treatment of TCS patients can be a real challenge for dentists due 
to patient anxiety, limited mouth opening ability, hearing impairment 
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and micrognathia, which contribute to the development of respiratory 
problems. Given the difficult intubation of these patients, dental 
treatment under general anaesthesia may be safer than outpatient or 
sedation intervention [28].
Orthodontics in conjunction with orthognathic surgery allows us 
to correct jaw and jaw growth defects [39,44]. These patients usually 
have no teeth or misplaced teeth. In this way, orthodontics can help 
improve bite and intercuspidation. However, in many cases extractions 
and implant placement may be necessary, as the various surgical 
interventions associated with bone deficiency make any damage to the 
roots of the tooth more likely [20,45].
In these patients, oral hygiene can be a problem. Dalben, et al. [28] 
demonstrated a high rate of plaque resulting from poor tooth brushing. 
This leads to a high frequency of restorative needs. In this context, 
there is a great need to establish a regular dental follow-up program 
for these patients. Caregivers should be informed of the importance of 
maintaining daily oral hygiene and should encourage patients to take 
responsibility for their care at home [28].
Prognosis
Treacher Collins syndrome is not a progressive disease and, in most 
cases, affected children achieve normal development and intelligence.
The prognosis of mild and moderate forms of this disease is 
favourable with the implementation of appropriate treatment. However, 
careful and insightful attention will ensure better school performance 
[35].
Discussion
Treacher Collins syndrome is a congenital disease associated with 
bilateral symmetrical anomalies of structures originating from the 1st 
and 2nd pharyngeal arches [8]. It is a condition with high penetrance 
and variable expressivity. If a parent is affected by this syndrome, there 
is a 50% probability of transmitting to the offspring the mutant gene 
responsible for the disorder [46].
The main gene involved in the development of TCS is TCOF1, 
present in the long arm of chromosome 5, which encodes the Treacle 
protein [47]. Although there has been strong progress in the molecular 
characterization of this syndrome, there is still no explanation for its 
variability of clinical manifestations, even in patients of the same family 
[10].
In Treacher Collins syndrome, both jaw and jaw are hypoplastic. 
Dental malocclusion is frequent due to hypoplasia of the mandible and 
ogival palate. In most cases the predominant dental malocclusion is 
crowding, mainly due to bone base deficiency [48,49].
In this context, dental treatment, especially orthodontic treatment, 
plays an important role.
Macrostomy and cleft palate appear in 35% of cases [16,50]. 
According to Thomé [51], cleft palate involvement is a very important 
factor regarding breastfeeding and feeding difficulties presented by 
these individuals. The cleft palate directly impairs the negative pressure 
that the baby exerts on the mouth during breastfeeding, which often 
makes milk suction difficult [31]. In this sense, the dentist plays a 
fundamental role in determining the need for diet adequacy according 
to the degree of oral changes, as well as guiding parents about feeding 
techniques and aspiration prevention.
These patients require special attention from dentists, since the 
alterations observed in the stomatognathic system, as well as the oral 
manifestations, negatively affect the oral health.
The diagnosis of TCS is mainly clinical and is usually made soon 
after birth. It can also be performed prenatally by ultrasonography and 
biopsy of chorionic villi. Moreover, many investigators recommend 
diagnostic confirmation through molecular testing and, in some cases, 
a detailed and careful family history as TCS shares several phenotypic 
features with other craniofacial syndromes.
The treatment of these patients is long and has a major impact on 
their lives and their families. Treatment usually requires numerous 
surgeries with numerous facial structures needing surgical correction. 
Therefore, it is important that these interventions be performed at an 
appropriate age in order to proceed without causing compromise in 
other procedures that may be requested later [8].
Therefore, therapeutic strategies for TCS patients require a 
multidisciplinary medical team, where all aspects of the disorder 
should be evaluated.
Conclusion
Although TCS is a rare congenital disease, it is important to know 
it so that an early diagnosis can be made to provide the patient with the 
best possible treatment, knowing that it is not just a dental intervention 
but a multidisciplinary team, where each plays a different role to 
improve the patient's quality of life. In this context, further studies 
are needed for a better understanding of the etiopathogenesis of this 
syndrome, which will guide therapeutic solutions for prevention and 
correction of both functional and aesthetic changes.
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